Racial disparities in cancer care persist, highlighting the need for culturally responsive education that prepares healthcare professionals to understand the social, cultural, and structural factors influencing African American (AA) community experiences. This study explored AA community perspectives to inform the development of culturally responsive cancer education for healthcare professionals and trainees. Thirty participants, 93.3
New symptoms after cancer may be due to a recurrence, another malignancy, treatment consequences or an unrelated illness. This narrative review examines the evidence relevant to symptom assessment and continuing education for practising primary-care clinicians. We searched PubMed, Embase and Scopus for publications published between 1 January 2000 and 1 October 2026, supplemented by reference-list checking. Educational needs, programme evaluations and care arrangements were synthesised narratively, with related reports considered together. The synthesis included 50 care-and-education publications and 15 supporting sources. Findings highlighted primary care’s role in recurrence detection, alongside gaps in treatment knowledge, information access, clinical decisions and coordination. Clinical evidence supported considering malignant, treatment-related and unrelated explanations. Educational programmes reported knowledge and confidence gains but improvements in symptom assessment and patient outcomes remained unproven. Follow-up trials supported primary-care participation in selected populations without isolating education’s contribution. Workload, unclear responsibilities and communication barriers constrained implementation, while heterogeneous evaluations limited comparisons between approaches. Continuing education should connect treatment knowledge with assessment, proportionate action and completed follow-up. Its evaluation should examine decisions and patient experience rather than rely on confidence or intention. A five-task educational framework is proposed for testing but not as a validated clinical algorithm.
Continuing professional development (CPD) involves continuing medical education (CME) and educational activities to develop research, teaching and leadership skills. Given limited literature specific to radiation oncologists (ROs), we sought to evaluate current CPD practices and identify unmet needs and barriers among ROs. An online survey was developed and emailed to ROs across Canada. CPD practices, preferences, barriers and needs were explored. Descriptive, univariable and multivariable analyses were performed. A total of 122 ROs completed the survey, with a median 12 years of experience (IQR: 5–21) and 96
Black female cancer survivors remain underrepresented in clinical trials. Social drivers of health are contributors to trial participation but remain understudied in the context of Black survivors’ trial knowledge and awareness. This cross-sectional survey included Black breast and gynecological cancer. Outcomes, clinical trial knowledge, and clinical trial awareness were measured using six- and one-item scales, respectively. Other factors include demographic factors and social drivers of health. Odds ratios were estimated to evaluate unadjusted and adjusted associations between the demographic and social drivers of health factors and the two aforementioned outcomes. Among 161 survivors (mean age = 53 ± 11.26), the majority had complete clinical trial knowledge (80.7
Unsupported anticancer supplement beliefs may inform priorities for cancer education. This cross-sectional study examined associations among these beliefs, supplement purchase/use intentions, trust in artificial intelligence (AI)-generated health information, and intentions to share such information. We analyzed baseline data from an online trial conducted in Japan in April 2026 among 939 adults aged 18–64 years with generative AI experience and no personal history of cancer. Multivariable linear regressions and partial correlations adjusted for sociodemographic characteristics and relevant covariates; analyses involving education included 919 participants. Mean belief, purchase/use intention, and sharing intention scores were 2.75, 2.73, and 2.59, respectively, on six-point scales. All four variables were positively intercorrelated (all p < .001), most strongly for unsupported beliefs and purchase/use intention (partial r = .634). Stronger unsupported beliefs and greater AI trust were independently associated with sharing intention (standardized β = 0.311 and 0.197, respectively; both p < .001). Lower education and self-rated supplement knowledge were associated with stronger unsupported beliefs. Higher self-reported communicative and critical health literacy was associated with greater purchase/use intention, trust, and sharing intention. More frequent generative AI use was associated with greater trust; younger age and female sex were associated with greater sharing intention. Cancer education for the general public should address unsupported supplement beliefs, calibrated trust in AI, and verification before sharing. These cross-sectional findings concern self-reported beliefs and intentions and do not establish causal relationships.
